Fundraising FoxEleven Tx
2 known investors
Find your way into Eleven Tx
Sign up to see every warm intro you have to Eleven Tx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eleven Tx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Eleven Therapeutics develops mRNA therapeutics by combining synthetic chemistry with AI, using massively-parallel processes to map RNA chemical space and determine structure-activity relationships. The platform optimizes RNA molecules for safety, efficiency, and duration of effect.
Founders & leadership
Investors · 2
Entrée Capitallisted by Entrée CapitalTel Aviv · $150K – $15M
How we know: Entrée Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Eleven Tx do?
- Eleven Therapeutics develops mRNA therapeutics by combining synthetic chemistry with AI, using massively-parallel processes to map RNA chemical space and determine structure-activity relationships. The platform optimizes RNA molecules for safety, efficiency, and duration of effect.
- Who founded Eleven Tx?
- Eleven Tx was founded by Adi Gilboa-Geffen, Shaul Ilan, Yaniv Erlich.
- Who are Eleven Tx's investors?
- Eleven Tx's investors include Entrée Capital, Kindred Capital.